BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
March 15, 2006
View Archived Issues
Running The Business’ Now Again Focus For SkyePharma
LONDON - SkyePharma plc rebuffed activist shareholders at an extraordinary general meeting (EGM) last week, with 53 percent of shareholders voting against rebel demands to appoint their man, Bob Thian, as chairman. (BioWorld International)
Read More
Aresa Raises DKK54M To Fund Trials Of Mine-Detecting Plants
Read More
Study Pinpoints Hypertension Role For Blood Vessel Protein
Read More
Industry Demanding Right To Choose Regarding GM Crops
Read More
Acambis Outlines Defense For Bavarian Nordic’s MVA Claims
Read More
Egalet Gets $27.6M For Trials Of Controlled-Release Drugs
Read More
BioBank Officially Starts Gathering Genetic Data
Read More
Once Profitable, Flamel Now Losing Money: $27M In 2005
Read More
Other News To Note
Read More